ITRM20030363A0 - COMPOSITIONS INCLUDING 3, 5DIIODOTYRONINE AND DIESSE PHARMACEUTICAL USE. - Google Patents

COMPOSITIONS INCLUDING 3, 5DIIODOTYRONINE AND DIESSE PHARMACEUTICAL USE.

Info

Publication number
ITRM20030363A0
ITRM20030363A0 IT2003RM000363A ITRM20030363A ITRM20030363A0 IT RM20030363 A0 ITRM20030363 A0 IT RM20030363A0 IT 2003RM000363 A IT2003RM000363 A IT 2003RM000363A IT RM20030363 A ITRM20030363 A IT RM20030363A IT RM20030363 A0 ITRM20030363 A0 IT RM20030363A0
Authority
IT
Italy
Prior art keywords
diesse
compositions including
pharmaceutical use
pharmaceutical
compositions
Prior art date
Application number
IT2003RM000363A
Other languages
Italian (it)
Inventor
Fernando Goglia
Antonia Lanni
Maria Moreno
Assunta Lombardi
Original Assignee
Fernando Goglia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fernando Goglia filed Critical Fernando Goglia
Priority to IT000363A priority Critical patent/ITRM20030363A1/en
Publication of ITRM20030363A0 publication Critical patent/ITRM20030363A0/en
Priority to PCT/IT2004/000402 priority patent/WO2005009433A1/en
Publication of ITRM20030363A1 publication Critical patent/ITRM20030363A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT000363A 2003-07-24 2003-07-24 COMPOSITIONS INCLUDING 3THIODOTYRONIN AND PHARMACEUTICAL USE OF THEM. ITRM20030363A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT000363A ITRM20030363A1 (en) 2003-07-24 2003-07-24 COMPOSITIONS INCLUDING 3THIODOTYRONIN AND PHARMACEUTICAL USE OF THEM.
PCT/IT2004/000402 WO2005009433A1 (en) 2003-07-24 2004-07-22 Use of 3,5 diiodothyronine as regulators of lipid metabolism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000363A ITRM20030363A1 (en) 2003-07-24 2003-07-24 COMPOSITIONS INCLUDING 3THIODOTYRONIN AND PHARMACEUTICAL USE OF THEM.

Publications (2)

Publication Number Publication Date
ITRM20030363A0 true ITRM20030363A0 (en) 2003-07-24
ITRM20030363A1 ITRM20030363A1 (en) 2005-01-25

Family

ID=29765933

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000363A ITRM20030363A1 (en) 2003-07-24 2003-07-24 COMPOSITIONS INCLUDING 3THIODOTYRONIN AND PHARMACEUTICAL USE OF THEM.

Country Status (2)

Country Link
IT (1) ITRM20030363A1 (en)
WO (1) WO2005009433A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7504435B2 (en) 2001-01-31 2009-03-17 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method for stimulating weight loss and/or for lowering triglycerides in patients
EP2428516A1 (en) 2003-11-19 2012-03-14 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
EP1898926A2 (en) 2005-05-26 2008-03-19 Metabasis Therapeutics, Inc. Thyromimetics for the treatment of fatty liver diseases
US8399518B2 (en) 2007-02-27 2013-03-19 University Of Arizona Office Of Technology Transfer Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome
EP1992341A1 (en) * 2007-05-16 2008-11-19 Université Joseph Fourier New pharmaceutical compositions comprising a thyroid hormon and their therapeutic use
WO2008138993A1 (en) * 2007-05-16 2008-11-20 Universite Joseph Fourier New pharmaceutical compositions comprising diiodothyronine and their therapeutic use
NZ582273A (en) 2007-06-06 2011-06-30 Torrent Pharmaceuticals Ltd Thyroid like compounds
US20120065267A1 (en) * 2010-09-09 2012-03-15 T*Amine, Llc Compositions including 3,5-l-t2 and methods of use thereof
US20130005814A1 (en) * 2011-07-01 2013-01-03 Thomas Najarian Methods and compositions for facilitating weight loss by administration of thyroid hormones
CN108101851A (en) 2012-09-17 2018-06-01 马德里加尔制药公司 The method of synthetic thyroid hormone analogs and its polymorph
JP2019533019A (en) 2016-10-18 2019-11-14 マドリガル ファーマシューティカルズ インコーポレイテッドＭａｄｒｉｇａｌ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． Methods for treating liver or lipid disorders with THR-beta agonists
AU2017363206A1 (en) 2016-11-21 2019-06-13 Viking Therapeutics, Inc. Method of treating glycogen storage disease
JP7168660B2 (en) 2017-06-05 2022-11-09 バイキング・セラピューティクス・インコーポレイテッド Compositions for the treatment of fibrosis
EA202091979A1 (en) 2018-03-22 2021-06-22 Вайкинг Терапьютикс, Инк. CRYSTALLINE FORMS AND METHODS FOR OBTAINING CRYSTALLINE FORMS OF COMPOUNDS
US12102646B2 (en) 2018-12-05 2024-10-01 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation
US12377104B1 (en) 2024-02-06 2025-08-05 Madrigal Pharmaceuticals, Inc. Methods for treating a fatty liver disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2950315A (en) * 1956-06-18 1960-08-23 Baxter Laboratories Inc Production of 3, 5-diiodothyronine
FR2197577A1 (en) * 1972-08-30 1974-03-29 Ind Chimi Ue Sa Hypocholesterolaemic, antiatheroma agents - 3,5-diiodo-4-(3-iodo-4-alkoxy-carbonyl phenoxy) phenylalkanoic acids, esters and salts
FR2501505A1 (en) * 1981-03-11 1982-09-17 Ana Laboratoires NOVEL MEDICINES FOR THE TREATMENT OF 3,5-DIIODO-3'-ISOPROPYL-THYROACETIC ACID-BASED HYPERLIPIDEMIA AND HYPERCHOLESTEROLEMIMIA
DE4026600A1 (en) * 1990-08-23 1992-02-27 Henning Berlin Gmbh AGENTS FOR TSH SUPPRESSION AND TREATMENT OF STRUMA
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
GB9401879D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401891D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
AU2003225305A1 (en) * 2002-05-08 2003-11-11 Bristol-Myers Squibb Company Pyridine-based thyroid receptor ligands

Also Published As

Publication number Publication date
ITRM20030363A1 (en) 2005-01-25
WO2005009433A1 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
ITMI20031570A1 (en) COMPOSITION FOR DIETARY, PHARMACEUTICAL OR COSMETIC USE
ITTO20010005A0 (en) PHARMACEUTICAL FORMULATION.
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
ITTO20000779A0 (en) PHARMACEUTICAL COMPOSITIONS.
RS50660B (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
NO20052306D0 (en) Dispersible pharmaceutical compositions.
DK1263720T3 (en) Acetidine derivatives, their preparation, and pharmaceutical compositions containing the same
BRPI0407755B1 (en) catalytic composition, preparation and use
BR0115810B1 (en) surfactant-free cosmetic, dermatological and pharmaceutical compositions.
IL174479A (en) Hemiasterlin derivatives, pharmaceutical compositions comprising the same and uses thereof
NL1025404A1 (en) Pyrazolo-triazine compounds and use thereof.
PL375874A1 (en) 2,6-Diisopropylphenol aqueous pharmaceutical compositions
ITRM20030363A0 (en) COMPOSITIONS INCLUDING 3, 5DIIODOTYRONINE AND DIESSE PHARMACEUTICAL USE.
PL394604A1 (en) Vinylazocycloalkanyl derivative, the use thereof and pharmaceutical composition
ITMI20031396A1 (en) COMPOSITION FOR PHARMACEUTICAL OR DIETETIC OR COSMETIC USE WITH ANTIOXIDANT ACTIVITY.
BR0208566B1 (en) Beta-Carboline Derivatives, Their Use, and Pharmaceutical Composition
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
BRPI0313645A2 (en) inhalation compositions with high drug ratios.
NO20052478D0 (en) Vitamin D analogues, compositions comprising the analogues and their use.
IT1318401B1 (en) N-DESACETYLTHIOCOLCHYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN.
EP1682088A4 (en) ORAL MICROEMULSION COMPOSITION COMPRISING BIPHENYLDIMETHYLDICARBOXYLATE AND SILYBINE
ITRM20020119A1 (en) COMPOSITIONS CONTAINING PLGF FOR PHARMACEUTICAL AND COSMETIC USE.
PT1358159E (en) TARTRATO AND PHOSPHATE 3.4 DIAMINOPYRIDINE, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USES
SV2004001441A (en) ISOCROMANO COMPOUNDS REF. X-14205
NL1025908A1 (en) Pharmaceutical combination.